Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4904]

ESMO 2022: A new era of early cancer detection with blood test may change cancer screening paradigms

ESMO 2022: A new era of early cancer detection with blood test may change cancer screening paradigms

ESMO 2022: Strong potential for neoadjuvant nivolumab plus ipilimumab to become standard of care for locally advanced MMR-deficient colon cancer

ESMO 2022: Strong potential for neoadjuvant nivolumab plus ipilimumab to become standard of care for locally...

ICR criticises NICE rejection of olaparib for advanced prostate cancer

ICR criticises NICE rejection of olaparib for advanced prostate cancer

NICE recommends oral maintenance therapy for AML after induction therapy

NICE recommends oral maintenance therapy for AML after induction therapy

Simple blood test predicts neurotoxic complications of CAR-T cell therapy

Simple blood test predicts neurotoxic complications of CAR-T cell therapy

Technological advances in cancer therapy

Technological advances in cancer therapy

Researchers report encouraging immunotherapy option for relapsed myeloma patients

Researchers report encouraging immunotherapy option for relapsed myeloma patients

The structure of protein RAF1 revealed: a key step in the development of new drugs against lung cancer

The structure of protein RAF1 revealed: a key step in the development of new drugs against lung cancer

Breast MRI illuminates risk of second breast cancer

Breast MRI illuminates risk of second breast cancer

$FDA approves pemigatinib for relapsed or refractory myeloid/lymphoid neoplasms with FGFR1 rearrangement$

FDA approves pemigatinib for relapsed or refractory myeloid/lymphoid neoplasms with FGFR1 rearrangement

More from ecancer